StockDiagnosis

Shared Analysis

META

Meta Platforms Inc.

Bullish

Meta keeps beating earnings estimates with strong growth and a reasonable valuation, signaling healthy momentum.

Overall Diagnosis

Meta is firing on all cylinders, growing revenue 33% and earnings 62% year-over-year while keeping profit margins high at 33%. With a P/E of 22, the stock looks fairly priced for its growth. Wall Street analysts remain positive on the name.

Earnings

Meta has beaten EPS estimates for four straight quarters, with surprises ranging from 7% to nearly 22%. The most recent quarter delivered $7.31 versus $6.82 expected. This consistent outperformance shows the business is executing well and earnings are growing fast.

News

Recent news is mostly neutral to positive, with Meta appearing in top Wall Street analyst research calls. Most headlines center on the broader AI and tech sector rather than Meta-specific issues, suggesting no major negative catalysts driving the stock right now.

Analyze your own stocks

3 free analyses every month. No credit card required.

Try StockDiagnosis Free

Analyzed Jun 2, 2026 · Not financial advice